Sign in Pull a receipt

KYTX

Kyverna Therapeutics, Inc.

Biotechnology · Biotechnology

$282.59 sample

-3.72 (-1.30%) 1D

Market cap

$1.35T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-19

Alerts

8

Price$282.59 +2.03% 3M daily closessample

288.37263.38

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: Chief Executive Officer
Oct 19SECDEF 14A filed
Oct 08INSInsider sell: Chief Financial Officer
Sep 29SECForm 144 filed
Sep 22INSInsider sell: EVP, Operations
Sep 15INSInsider buy: Chief Executive Officer
Sep 08INSInsider buy: General Counsel
Sep 02INSInsider sell: EVP, Operations

Sign up to see the real KYTX record →

Company facts

SEC EDGAR registration

Name: Kyverna Therapeutics, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +9sample, -100 to +100
Reporting currency: USD

Who is positioning in KYTX

sample

Insiders: 18 insider transactions over 90 days, net selling, $567.0M
Congress: 3 members traded over 90 days
Institutions · 13F: 22 funds hold $29.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$74.1B +11.8% y/y

Q4 2024Q3 2026

Inventory$46.4B +9.8% y/y

Q4 2024Q3 2026

Accounts receivable$35.5B +12.6% y/y

Q4 2024Q3 2026

Total debt$88.6B +5.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.11T +7.8% 3M
Sample peer B: $1.26T -6.7% 3M
Sample peer C: $258.6B +14.0% 3M
Sample peer D: $867.9B -13.3% 3M
Sample peer E: $350.7B -6.2% 3M